Single Dose, Pharmacokinetic, Safety, Tolerability and QTc Study of GSK1278863 in Healthy Volunteers

NCT02293148 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Anaemia

Interventions

DRUG: GSK1278863 75 mg
DRUG: GSK1278863 500 mg
DRUG: Moxifloxacin 400 mg
DRUG: Placebo matching GSK1278863
DRUG: Placebo matching Moxifloxacin

Sponsor

GlaxoSmithKline